GLOW vs KLOW: How the Two Peptide Blends Compare

GLOW and KLOW are two multi-peptide research blends that share most of their contents. The difference is one added tripeptide. This comparison of GLOW vs KLOW covers what is in each vial, what KPV adds as a research variable, and when a lab would choose a blend over single compounds. Both are research-use-only materials.

What is the difference between GLOW and KLOW?

GLOW combines three peptides, GHK-Cu, BPC-157, and TB-500, while KLOW contains those same three plus KPV.

Both are physical blends, not single molecules. Each peptide in the vial keeps its own structure and chemistry. So neither blend has one molecular formula, CAS number, or molecular weight. Each component carries its own.

• GLOW: GHK-Cu, BPC-157, and TB-500 in a 70 mg vial.
• KLOW: GHK-Cu, BPC-157, TB-500, and KPV in an 80 mg vial.
• Shared core: three peptides studied in matrix remodeling, tissue repair signaling, and cell migration.
• The added variable: KPV, studied in inflammatory signaling models.

What is the GLOW peptide, and why is it called GLOW 70?

The GLOW peptide is a three-component blend supplied as 70 mg total per vial, which is where the name GLOW 70 comes from.

A common formulation pairs 50 mg of GHK-Cu with 10 mg of BPC-157 and 10 mg of TB-500. GHK-Cu makes up most of the mass. That is why the powder has a blue tint. The color comes from the copper(II) ion bound to the GHK tripeptide. BPC-157 and TB-500 on their own are white.

Each component brings a separate line of research:

• GHK-Cu is the copper complex of glycyl-L-histidyl-L-lysine. It is studied for copper delivery, fibroblast collagen and glycosaminoglycan synthesis, and regulation of matrix metalloproteinases, the enzymes that break down extracellular matrix. Its CAS number is 89030-95-5 (the free GHK peptide, without copper, is 49557-75-7).
• BPC-157 is a synthetic 15-amino-acid peptide based on a gastric protein sequence. It is studied for cytoprotective signaling, nitric oxide pathways, and growth factor receptor systems, including VEGFR2. Its CAS number is 137525-51-0.
• TB-500 corresponds to the actin-binding region of thymosin beta-4. It is studied for actin sequestration, cell migration, and angiogenesis, the growth of new blood vessels.

The GHK-Cu mechanism of action article covers the copper chemistry in depth. The BPC-157 vs TB-500 comparison sets out how the other two differ.

What is the KLOW peptide, and what is in KLOW 80?

The KLOW peptide is a four-component blend supplied as 80 mg total per vial: the three GLOW peptides plus KPV.

The name is drawn from its constituents. Because KLOW is a mixture of four peptides, its composition is documented on the lot certificate of analysis rather than as a single formula. The powder is white to off-white and may show a faint blue tint from the GHK-Cu.

KLOW is used to evaluate a panel of tissue repair and signaling peptides in one system. Its studied endpoints include wound-model, extracellular matrix, and angiogenesis measures in cell cultures and animal models. It adds inflammatory signaling and directed cell migration to that list.

What does KPV add as a research variable?

KPV adds an inflammatory signaling arm, centered on the NF-kB pathway, that GLOW does not include.

KPV is a synthetic tripeptide, lysine-proline-valine. It matches positions 11 to 13 of alpha-melanocyte-stimulating hormone, or alpha-MSH. Research indicates this short fragment keeps much of the anti-inflammatory character of alpha-MSH without its pigment-stimulating activity. Its CAS number is 67727-97-3, and its molecular weight is about 342.43 g/mol.

In cell models, KPV has been linked to preserved IkB-alpha and reduced nuclear translocation of NF-kB. These events connect to lower expression of cytokines such as TNF-alpha, IL-1beta, and IL-6 under experimental conditions. KPV is also characterized as a substrate for PepT1, a small-peptide transporter in intestinal epithelial cells. The KPV mechanism of action article covers both routes.

For study design, a GLOW arm and a KLOW arm differ by one variable. Comparing them is one way to ask what an NF-kB-associated input contributes alongside matrix and migration endpoints. A separate KPV arm helps confirm that an effect traces to KPV itself.

When would a lab choose GLOW or KLOW over single compounds?

A blend fits when the question is about combined behavior in one model. Single compounds fit when each input must be varied or controlled on its own.

• Choose GLOW to study matrix remodeling, cytoprotective signaling, and cell migration together, without an inflammatory signaling arm.
• Choose KLOW when NF-kB-associated inflammatory signaling should be part of the same panel.
• Choose single compounds when ratios must change between arms, when each peptide needs its own control, or when the question concerns one mechanism.

A fixed-ratio blend cuts weighing steps and ratio error between vials. The tradeoff is that the ratio is locked. Many designs run the blend next to its components. That is how both blends appear in comparative work: to separate independent effects from overlapping ones.

How are GLOW and KLOW handled in the lab?

Both ship as lyophilized powder in a sealed glass vial and share the same storage guidance.

• Store sealed at or below 25 degrees Celsius, away from heat, light, and moisture.
• For extended storage, keep the material lyophilized and refrigerated or frozen.
• Follow standard precautions for handling and disposing of metal complexes, since both contain copper.
• Record lot numbers, blend composition, and storage conditions.

The blue tint is a useful check. Watch for color changes as part of routine quality control. For KLOW, confirm the handling guidance for each constituent. Every batch ships with a third-party certificate of analysis covering HPLC purity and mass-spectrometry identity. Puritide Research sources and independently tests these blends. It does not make them in-house.

For research use only. GLOW and KLOW are laboratory research blends supplied for in vitro and preclinical investigation. Neither is supplied for human or veterinary use, and nothing above is medical or cosmetic guidance or a description of outcomes in people.